Volume 5, Issue 4 (2019)                   Pharm Biomed Res 2019, 5(4): 69-74 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Gheibi S, Farsavian A, Nabati M, Eslami G. Successful Use of Two Thrombolytic Drugs in Prosthetic Mitral and Aortic Valve Thrombosis. Pharm Biomed Res. 2019; 5 (4) :69-74
URL: http://pbr.mazums.ac.ir/article-1-271-en.html
1- Department of Clinical Pharmacy, Cardiovascular Research Center, School of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
2- Department of Cardiology, School of Medicine Cardiovascular, Research Center, Sari Fatemeh Zahra Hospital, Mazandaran University of Medical Sciences, Sari, Iran.
Abstract:   (1076 Views)
Introduction: Prosthetic valve thrombosis is a rare and severe complication of valve replacement, most often encountered with a mechanical prosthesis. The significant morbidity and mortality associated with this condition warrant rapid diagnostic evaluation. Although surgery is the first-line therapy in symptomatic obstructive mechanical valve thrombosis, thrombolytic therapy has been used as an alternative. 
Case Description: In this case report, we describe a 46-year-old man with a history of the mitral valve and aortic valve replacement 2 years ago. In echocardiography, we detected a mobile mass on the atrial side of the mitral valve prosthesis and a fixed one on the leaflet of the mechanical aortic valve with a high gradient. To save his life, we used double thrombolytic therapy considering the patient’s hemodynamic situation and the risk of bleeding. Although a routine dose of reteplase and streptokinase was considered, we administered these two thrombolytic drugs together within 72 hours. 
Conclucsion: Ultimately we succeeded with this method without any significant or life-threatening adverse effects, and the patient was discharged after an optimal anticoagulation therapy.
Full-Text [PDF 1707 kb]   (992 Downloads)    
Type of Study: case report | Subject: Clinical Pharmacy

Add your comments about this article : Your username or Email:

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Pharmaceutical and Biomedical Research

Designed & Developed by : Yektaweb